Generics and Pharmaceuticals

///Generics and Pharmaceuticals

More generic drugs were approved by the US FDA in FY 2017 than ever before.

By the end of the 2017 fiscal year in September, the US Food and Drug Administration had approved 763 new generic versions of drugs—112 more than it had in 2016, almost twice as many as in 2014. This record push is part of an effort to lower prescription drug costs. Generic drugs, which work the same way

FDA aims to speed up arrival of complex generic drugs

The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV’s emergency EpiPen in an effort to address the rising cost of pharmaceuticals. The measures, announced in a blog post by Commissioner Scott Gottlieb, stray into an area that

Drug prices: how generics changed the game

For a time, high drug prices made headlines, and it looked like the issue could be tackled by the Trump administration. But as we all know, efforts to repeal Obamacare have consumed Republicans much of this year. The drug problem hasn’t gone away; it’s just lingering in the background. Even the cost of some generic drugs

Take the Generic Drug, Patients Are Told — Unless Insurers Say No

Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more. Adderall XR, a drug to treat attention-deficit hyperactivity disorder, is a case in point. It’s standard advice for consumers: If you are prescribed a medicine, always ask

Why Big Pharma Is Struggling to Profit From the Obesity Epidemic

In a decades-long struggle to control her weight, Carolyn Mills joined the YMCA many times, signed up for the Jenny Craig diet program and tried fen-phen, the drug combination later found to damage heart valves. As her size yo-yoed down and back up, her health deteriorated. She finally found the answer in a new class of

2017-08-17T15:01:24+00:00 Tags: |

Curing America’s Expensive Drugs

The United States spent $457 billion on prescription drugs in 2015, nearly 17 percent of total healthcare spending. The Department of Health and Human Services estimates this figure will grow to $535 billion by 2018. Bringing a new drug to the market is notoriously expensive due to research and development, time opportunity costs, and jumping through hoops for FDA

The generic drug industry has brought huge cost savings. That may be changing.

A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug. Doctors liked the brand-name drug Cerebyx because it was safer and easier to use than a previous medicine that stopped seizures but could

Worldwide Specialty Generics Market Report 2017-2027

Specialty Generics are the generic versions of specialty pharmaceutical products. They are cost-effective when compared with specialty pharmaceuticals. Specialty generics include biopharmaceuticals, blood derived products and complex molecules. Several blockbuster specialty drug molecules are coming off patent in the coming years. Hence, companies are foraying into this market to launch generic versions of the products

Increasing transparency on generic drug cost data could save $4 billion

Making actual generic drug acquisition costs available to third-party payers would empower health plans to negotiate lower rates and essentially level the playing field in a pharmaceutical supply chain that's shrouded in secrecy, according to a new paper. Making actual generic drug acquisition costs available to third-party payers would empower health plans to negotiate lower

Two Generic Medications Become One Expensive Drug – The Atlantic

I was prescribed a brand-name drug I didn’t need and given a coupon to cover the out-of-pocket costs. I had discovered yet another reason why Americans pay too much for health care. Everything happened so fast as I walked out of the doctor’s exam room. I was tucking in my shirt and wondering if I’d

2017-06-23T23:14:31+00:00 Tags: |

Nearly one in three drugs found to have safety concerns after FDA approval

How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event. The team defines postmarket safety

2017-05-11T07:48:11+00:00 Tags: |

Online pharmacies not requiring prescriptions could fuel antibiotic resistance

Scientists have found that antibiotics are illegally available without prescription on 45 per cent of online pharmacy websites surveyed, says study. The researchers from Imperial College London analysed 20 pharmacies that were available for UK citizens to access online. This is one of the few studies to have examined the online availability of antibiotics and

2017-02-21T10:43:05+00:00 Tags: |

World Trade Organization boosts poor countries’ ability to import generic drugs

Developing countries are expected to have greater access to generic pharmaceuticals under changes the World Trade Organization made in late January. WTO amended its intellectual property rules to allow developing countries that lack the infrastructure to produce generic drugs the ability to import the low-cost medicines under “compulsory licensing” arrangements. Compulsory licensing involves a government


How the U.S. can beat hepatitis C: Don’t buy the pills, buy the company

In a recent article in Forbes, MIT Sloan School of Management visiting scientist Mark Trusheim and co-author Peter B. Bach, a physician at Memorial Sloan Kettering Cancer Center in New York, propose a startling response to the prevalence of hepatitis C and the high cost of the leading therapy: The U.S. government should not just

2017-02-23T09:32:41+00:00 Tags: , |

Generics are better for the country, but the choice isn’t easy

If you’ve stepped into a pharmacy recently, you know that getting sick is going to cost you. All of those insurance premiums and co-pays got you a doctor’s appointment and prescription; now you’re going to have to pay much more than someone in another developed nation to get the medication you need. According to data

These Cheap Paper Tests Could Fight Against The Huge Counterfeit Drug Problem

Counterfeit drugs are a big problem in the developing world. Up to 30% of medicines sold in parts of Africa, Latin America, and Asia are fakes, according to figures from the World Health Organization. And the consequences sometimes can be deadly. In Pakistan, in 2012, more than 100 heart patients died after taking faulty drugs

2017-01-21T13:52:37+00:00 Tags: |

Medicare Part D generic drug prices fall nearly 60% since 2010, GAO finds

A new US Government Accountability Office (GAO) report finds that prices for generic drugs in Medicare Part D fell 59% from the first quarter of 2010 to the second quarter of 2015. This report comes at a time when an increasing number of public policy experts, supply chain stakeholders, economists and others recognize that over

2017-01-21T13:52:37+00:00 Tags: |

Replacing big pharma’s products: how good are the generic options?

Big pharma and its big price tags have been the target for many a politician seeking to lower the cost of health care in the U.S. Martin Shkreli and his questionable big-pharma persona are an easy target and embodiment of how some continue to squeeze increasing profits out of America’s declining health. Drug prices have


The Real Reason Big Pharma Wants to Help Pay for Your Prescription

This is not a feel-good story.  It’s a story about why expensive drugs  keep getting more expensive, and how U.S. taxpayers support a billion-dollar system in which charitable giving is, in effect, a very profitable form of investing for drug companies—one that may also be tax-deductible. Read more at  The Real Reason Big Pharma Wants to